DrugPatentWatch Database Preview
Sanofi Aventis Us Company Profile
» See Plans and Pricing
US Patents for Sanofi Aventis Us
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanofi Aventis Us | SARCLISA | isatuximab-irfc | INJECTABLE;INJECTION | 761113 | 002 | 2020-03-02 | 10,478,497 | HYBRIGENICS S.A. (Paris, FR) | 2039-12-05 | RX | Orphan | search |
| Sanofi Aventis Us | SARCLISA | isatuximab-irfc | INJECTABLE;INJECTION | 761113 | 002 | 2020-03-02 | 10,258,619 | Calithera Biosciences, Inc. (South San Francisco, CA) | 2035-10-05 | RX | Orphan | search |
| Sanofi Aventis Us | SARCLISA | isatuximab-irfc | INJECTABLE;INJECTION | 761113 | 001 | 2020-03-02 | 10,478,497 | HYBRIGENICS S.A. (Paris, FR) | 2039-12-05 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
Similar Applicant Names
Companies are sometimes listed under multiple names.
This search can help find similar names.
This search can help find similar names.
